The biology of metastases in pediatric sarcomas

Kartik Krishnan, Chand Khanna, Lee J. Helman

Research output: Contribution to journalArticle

Abstract

In the treatment of pediatric solid tumors, the presence or development of metastatic disease carries a universally poor prognosis. In fact, most cancer deaths result from metastases rather than primary tumor growth. Although the poor outcome associated with metastatic disease has been known for some time, an understanding of the processes that allow a cancer to disseminate is only now beginning to be understood. In order for a cancer to spread beyond its local site, a complex series of events must be undertaken that must allow the cancer not only to travel into and through the circulation but also prevent elimination of these cells by the host, as well as promote growth at the metastatic site. This review presents a current model of these processes. Some of the key molecular factors influencing their development are outlined in the context of this model. We present recent advances in our understanding of metastases, especially as they relate to experimental therapies and possible molecular targets of future therapies. Finally, we discuss progress being made in our ability to study metastases and expectations for the future.

Original languageEnglish (US)
Pages (from-to)306-313
Number of pages8
JournalCancer Journal
Volume11
Issue number4
DOIs
StatePublished - Jul 2005
Externally publishedYes

Fingerprint

Sarcoma
Pediatrics
Neoplasm Metastasis
Neoplasms
Investigational Therapies
Growth
Therapeutics

Keywords

  • Metastasis
  • Models
  • Sarcoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The biology of metastases in pediatric sarcomas. / Krishnan, Kartik; Khanna, Chand; Helman, Lee J.

In: Cancer Journal, Vol. 11, No. 4, 07.2005, p. 306-313.

Research output: Contribution to journalArticle

Krishnan, K, Khanna, C & Helman, LJ 2005, 'The biology of metastases in pediatric sarcomas', Cancer Journal, vol. 11, no. 4, pp. 306-313. https://doi.org/10.1097/00130404-200507000-00006
Krishnan, Kartik ; Khanna, Chand ; Helman, Lee J. / The biology of metastases in pediatric sarcomas. In: Cancer Journal. 2005 ; Vol. 11, No. 4. pp. 306-313.
@article{33035508c33a4312bdf8054716912386,
title = "The biology of metastases in pediatric sarcomas",
abstract = "In the treatment of pediatric solid tumors, the presence or development of metastatic disease carries a universally poor prognosis. In fact, most cancer deaths result from metastases rather than primary tumor growth. Although the poor outcome associated with metastatic disease has been known for some time, an understanding of the processes that allow a cancer to disseminate is only now beginning to be understood. In order for a cancer to spread beyond its local site, a complex series of events must be undertaken that must allow the cancer not only to travel into and through the circulation but also prevent elimination of these cells by the host, as well as promote growth at the metastatic site. This review presents a current model of these processes. Some of the key molecular factors influencing their development are outlined in the context of this model. We present recent advances in our understanding of metastases, especially as they relate to experimental therapies and possible molecular targets of future therapies. Finally, we discuss progress being made in our ability to study metastases and expectations for the future.",
keywords = "Metastasis, Models, Sarcoma",
author = "Kartik Krishnan and Chand Khanna and Helman, {Lee J.}",
year = "2005",
month = "7",
doi = "10.1097/00130404-200507000-00006",
language = "English (US)",
volume = "11",
pages = "306--313",
journal = "Cancer journal (Sudbury, Mass.)",
issn = "0765-7846",
publisher = "Association Pour le Developpement de la Communication Cancerologique",
number = "4",

}

TY - JOUR

T1 - The biology of metastases in pediatric sarcomas

AU - Krishnan, Kartik

AU - Khanna, Chand

AU - Helman, Lee J.

PY - 2005/7

Y1 - 2005/7

N2 - In the treatment of pediatric solid tumors, the presence or development of metastatic disease carries a universally poor prognosis. In fact, most cancer deaths result from metastases rather than primary tumor growth. Although the poor outcome associated with metastatic disease has been known for some time, an understanding of the processes that allow a cancer to disseminate is only now beginning to be understood. In order for a cancer to spread beyond its local site, a complex series of events must be undertaken that must allow the cancer not only to travel into and through the circulation but also prevent elimination of these cells by the host, as well as promote growth at the metastatic site. This review presents a current model of these processes. Some of the key molecular factors influencing their development are outlined in the context of this model. We present recent advances in our understanding of metastases, especially as they relate to experimental therapies and possible molecular targets of future therapies. Finally, we discuss progress being made in our ability to study metastases and expectations for the future.

AB - In the treatment of pediatric solid tumors, the presence or development of metastatic disease carries a universally poor prognosis. In fact, most cancer deaths result from metastases rather than primary tumor growth. Although the poor outcome associated with metastatic disease has been known for some time, an understanding of the processes that allow a cancer to disseminate is only now beginning to be understood. In order for a cancer to spread beyond its local site, a complex series of events must be undertaken that must allow the cancer not only to travel into and through the circulation but also prevent elimination of these cells by the host, as well as promote growth at the metastatic site. This review presents a current model of these processes. Some of the key molecular factors influencing their development are outlined in the context of this model. We present recent advances in our understanding of metastases, especially as they relate to experimental therapies and possible molecular targets of future therapies. Finally, we discuss progress being made in our ability to study metastases and expectations for the future.

KW - Metastasis

KW - Models

KW - Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=33749542027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749542027&partnerID=8YFLogxK

U2 - 10.1097/00130404-200507000-00006

DO - 10.1097/00130404-200507000-00006

M3 - Article

C2 - 16197720

AN - SCOPUS:33749542027

VL - 11

SP - 306

EP - 313

JO - Cancer journal (Sudbury, Mass.)

JF - Cancer journal (Sudbury, Mass.)

SN - 0765-7846

IS - 4

ER -